| Classification criteria for psoriatic arthritis: development of new criteria from a large international study W Taylor, D Gladman, P Helliwell, A Marchesoni, P Mease, H Mielants Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 4209 | 2006 |
| Current causes of death in systemic lupus erythematosus in Europe, 2000—2004: relation to disease activity and damage accrual J Nossent, N Cikes, E Kiss, A Marchesoni, V Nassonova, M Mosca, ... Lupus 16 (5), 309-317, 2007 | 326 | 2007 |
| The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) PS Helliwell, O FitzGerald, J Fransen, DD Gladman, GG Kreuger, ... Annals of the rheumatic diseases 72 (6), 986-991, 2013 | 319 | 2013 |
| A re-evaluation of the osteoarticular manifestations of psoriasis P Helliwell, A Marchesoni, M Peters, M Barker, V Wright Rheumatology 30 (5), 339-345, 1991 | 270 | 1991 |
| A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. C Salvarani, P Macchioni, I Olivieri, A Marchesoni, M Cutolo, G Ferraccioli, ... The Journal of Rheumatology 28 (10), 2274-2282, 2001 | 235 | 2001 |
| Prevalence and incidence of psoriatic arthritis: a systematic review and meta-analysis L Scotti, M Franchi, A Marchesoni, G Corrao Seminars in Arthritis and Rheumatism 48 (1), 28-34, 2018 | 211 | 2018 |
| Serious infections during anti-TNFα treatment in rheumatoid arthritis patients EG Favalli, F Desiati, F Atzeni, P Sarzi-Puttini, R Caporali, FB Pallavicini, ... Autoimmunity reviews 8 (3), 266-273, 2009 | 200 | 2009 |
| Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the … F Atzeni, P Sarzi-Puttini, C Botsios, A Carletto, P Cipriani, EG Favalli, ... Autoimmunity reviews 12 (2), 225-229, 2012 | 196 | 2012 |
| Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus J Nossent, E Kiss, B Rozman, G Pokorny, P Vlachoyiannopoulos, ... Lupus 19 (8), 949-956, 2010 | 195 | 2010 |
| The Italian version of the Functional Disability Index of the Health Assessment Questionnaire. A reliable instrument for R Ranza, A Marchesoni, G Calori, G Bianchi, M Braga, S Canazza, ... Clinical and experimental rheumatology 2, 123-128, 1993 | 195 | 1993 |
| TNF‐α antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice A Marchesoni, E Zaccara, R Gorla, C Bazzani, P Sarzi‐Puttini, F Atzeni, ... Annals of the New York Academy of Sciences 1173 (1), 837-846, 2009 | 190 | 2009 |
| Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal R Caporali, FB Pallavicini, M Filippini, R Gorla, A Marchesoni, EG Favalli, ... Autoimmunity reviews 8 (3), 274-280, 2009 | 162 | 2009 |
| Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation AJG Swaak, HG van Den Brink, RJT Smeenk, K Manger, JR Kalden, ... Rheumatology 38 (10), 953-958, 1999 | 154 | 1999 |
| Cutaneous lymphocyte antigen‐positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis C Pitzalis, A Cauli, N Pipitone, C Smith, J Barker, A Marchesoni, G Yanni, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1996 | 149 | 1996 |
| Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study A Cauli, DD Gladman, A Mathieu, I Olivieri, G Porru, PP Tak, C Sardu, ... The Journal of rheumatology 38 (5), 898-903, 2011 | 148 | 2011 |
| Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors F Iannone, E Gremese, F Atzeni, D Biasi, C Botsios, P Cipriani, C Ferri, ... The Journal of rheumatology 39 (6), 1179-1184, 2012 | 131 | 2012 |
| A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis WJ Taylor, A Marchesoni, M Arreghini, K Sokoll, PS Helliwell Seminars in arthritis and rheumatism 34 (3), 575-584, 2004 | 131 | 2004 |
| Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model PS Helliwell, J Hetthen, K Sokoll, M Green, A Marchesoni, E Lubrano, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 130 | 2000 |
| Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic … AJG Swaak, H Van de Brink, RJT Smeenk, K Manger, JR Kalden, S Tosi, ... Rheumatology 40 (1), 89-94, 2001 | 116 | 2001 |
| Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia A Marchesoni, F Atzeni, A Spadaro, E Lubrano, G Provenzano, A Cauli, ... The Journal of rheumatology 39 (4), 849-855, 2012 | 112 | 2012 |
